Xeomin 100 UT vial 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9LS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,441
Award facts
- Contract value 100% obligated
- $29,441.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $29,441.00 for XEOMIN 100 Unit vials. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 22, 2026, and represents a continuation of the company's substantial role as a pharmaceutical supplier to the federal government. The award is designated as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the delivery of pharmaceutical products, medical supplies, and specialized medications to military healthcare systems worldwide.
AmerisourceBergen Drug Corp continues to serve as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and other government healthcare systems through its DLA framework agreement. This delivery order reflects the company's demonstrated capability to fulfill competitive federal procurement requirements for specialty pharmaceuticals and medical supplies. The contract carries no set-aside designation and was awarded through open competition, consistent with AmerisourceBergen's portfolio of federal medical supply contracts that range from small-value transactions to substantial orders, showcasing the vendor's versatility in meeting the Defense Logistics Agency's medical supply chain needs.
Quick answers
Who was awarded contract SPE2DR26FW9LS?
SPE2DR26FW9LS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FW9LS worth?
The government has obligated $29,441 on SPE2DR26FW9LS.
Is contract SPE2DR26FW9LS an order under another contract?
Yes. SPE2DR26FW9LS is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9LS competed?
The extent of competition for SPE2DR26FW9LS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award